Overview
Blood cancer, or haematological malignancy, is a group of cancers that affect the production and function of blood cells, arising in the bone marrow, blood, or lymphatic system. The principal categories are the leukaemias, which involve clonal proliferation of white-cell precursors in the marrow; the lymphomas, which arise from lymphocytes within lymphoid tissue; and the plasma-cell disorders, including multiple myeloma. These malignancies result from mutations and chromosomal abnormalities that disrupt normal haematopoiesis and immune function, producing anaemia, infection, bleeding, and organ involvement. Diagnosis relies on blood counts, bone-marrow examination, immunophenotyping, cytogenetics, and molecular profiling, while treatment combines chemotherapy, targeted and immune therapies, radiotherapy, and stem-cell transplantation, with extensive transfusion support. Because management depends on blood products and the correction of cytopenias, blood cancers are intimately connected with transfusion medicine. The research themes connected here engage broader cancer biology and diagnostics, including stem-cell research ethics, immunoassays and immunogenomic approaches for monitoring cancer, and biomarker-development platforms, alongside studies of cancer screening, tumour-suppressor mutations, and molecular diagnostic technologies. Across these topics, malignant transformation, immune monitoring, and diagnostic innovation recur. The journal publishes peer-reviewed clinical and laboratory studies, case reports, and reviews addressing haematological malignancies and the transfusion-relevant aspects of cancer diagnosis and treatment.
Research published in this journal
12 peer-reviewed articles, ranked by relevance. Each links to its DOI.
Correlating 13C Isotope in Oligomeric Proanthocyanidins with their Anticancer Properties
High-Throughput Complex Disease Modeling for Ethical Drug Discovery: Clinical Relevance of a NAM Platform for Cancer Biomarker Development
The Current Immunoassays and Emerging Immunogenomic Approaches for Immunomonitoring Cancer and Infectious Diseases
Importance of Neutrophil/Lymphocyte Ratio in Squamous-Cell Carcinoma of the Larynx
A Roadmap to Developing a Population-Based Colorectal Cancer Screening Program in Oman
Use of Microfluidic Assays to Develop Reliable and Economic Nucleic Acid Application Technologies, Employing MicroRNAs for the Diagnostic Screening of Colon Cancer in Human Stool in Low-Resource Settings
Use of Microfluidic Assays to Develop Reliable and Economic Nucleic Acid Application Technologies, Employing MicroRNAs for the Diagnostic Screening of Colon Cancer in Human Stool in Low-Resource Settings
Complementary and Alternative Treatments for Cancer Prevention and Cure (Part 1)
Targeting Mutational Landscape of TP53 in patients diagnosed with Oral Cancer living in Senegal
Compliance to Company Based Colorectal Cancer Screening in Germany using Fecal Immunochemical Test (FIT) - Results of Almost Half a Million FIT Tests
Preoperative and Postoperative N-terminal Pro B-type Natriuretic Peptide Levels Predict Cardiac Morbidity and Mortality in Patients Undergoing Colorectal Cancer Resection
How this research is being cited
The 12 articles above have been cited 20 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2026 · Genes
-
2025 · Journal of Onco-Anaesthesiology and Perioperative Medicine
-
2025 · Open Journal of Genetics
-
2023 · Biosensors
-
2023 · Biosensors
-
2023 · Cells
-
2023 · kulak burun boğaz ve baş boyun cerrahisi dergisi
-
2023 · Cells
A sample of recent works citing this journal's research on Blood Cancer, linking to each citing work.